US EditionPublished • loading... • Updated
John Newby: Virginia can lead biotech manufacturing renaissance – if policymakers help
Summary by The Daily Progress
1 Articles
1 Articles
John Newby: Virginia can lead biotech manufacturing renaissance – if policymakers help
Merck's new $3 billion facility in Virginia marks a significant investment in U.S. drug manufacturing, driven by supportive government policies and incentives for biotech companies. f Virginians want more groundbreaking ceremonies like this, we need those policymakers to keep incentivizing research, protecting intellectual property, and encouraging investments in lasting growth.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
